A significant discovery in cancer research is arising with the use of mini-antibodies to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in various types of malignancies, https://mylittlebookmark.com/story7764306/nanobodies-restore-tumor-suppressor-p53-the-promising-pathway-for-malignant-therapy